tiprankstipranks
Trending News
More News >
Y-Mabs Therapeutics (YMAB)
:YMAB
US Market

Y-Mabs Therapeutics (YMAB) Similar Stocks

Compare
516 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Y-Mabs Therapeutics
$4.60
$208.30M
-61.89%
9 Buy
0 Hold
2 Sell
Moderate Buy
Anika Therapeutics
$11.15
$159.91M
-58.21%
3 Buy
0 Hold
0 Sell
Strong Buy
Cardiff Oncology
$3.41
$226.85M
7.57%
6 Buy
0 Hold
0 Sell
Strong Buy
Neurogene
$17.01
$242.60M
-54.31%
6 Buy
1 Hold
0 Sell
Strong Buy
Nevro Corp
$5.84
$224.09M
-37.54%
0 Buy
9 Hold
0 Sell
Hold
Outset Medical
$17.57
$311.01M
-69.34%
3 Buy
2 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
YMAB
Y-Mabs Therapeutics
4.60
-7.47
-61.89%
ANIK
Anika Therapeutics
11.15
-15.53
-58.21%
CRDF
Cardiff Oncology
3.41
0.24
7.57%
NGNE
Neurogene
17.01
-20.22
-54.31%
NVRO
Nevro Corp
5.84
-3.49
-37.41%
OM
Outset Medical
17.57
-39.73
-69.34%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis